Perhaps there's nothing better today than a company that is logging very good growth with a set of products that are widely seen as economically-insensitive, day-to-day essentials. That has to be at least some of the explanation for the valuation of Colgate-Palmolive (NYSE:CL). For while this is absolutely an excellent company and a worthy buy-and-hold candidate for dividend-inclined investors, today's price is certainly no bargain.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Q4 Results - Good Growth, the Worst of the Margins?
Colgate-Palmolive reported revenue growth of nearly 5%, with organic growth of 6% split evenly between volume and price. Oral/personal care (which is the overwhelming bulk of sales) had reported sales growth above 5%. By region, North America saw marginal growth (3.5%), while Europe was actually down 2% on an organic basis. Latin America and Asia/Africa both posted double-digit organic revenue growth. (For related reading, see Analyzing Operating Margins.)

Margins continue to weigh on results. Colgate-Palmolive saw a five point headwind from input costs, so the fact that reported gross margin fell 170 basis points is actually a rather costly result in many respects. Still, the company wasn't able to offset that with further operating efficiencies; operating income fell about 2% on a 160 basis point contraction in operating margin.

2012 is Looking Encouraging
Colgate-Palmolive was surprisingly upbeat. Though hearing management blame "volatility" for its decision to change how it provides guidance was irritating, the fact is that 5 to 7% organic growth for 2012 is not irritating in the slightest, if the company can pull it off. Remember, Colgate-Palmolive's two largest rivals, Procter & Gamble (NYSE:PG) and Unilever (NYSE:UL), are both explicitly targeting market share growth at the cost of profitability, so that should be a fairly rough environment in which to post that sort of growth.

Investors may have reason to hope for a one-two punch of better growth and improving margins, to really improve reported results. Throughout 2012 Colgate will be annualizing some pretty unappetizing input cost increases, but should also be seeing some deceleration in that inflation, unless things go really haywire in the energy and petrochemical markets.

A Name to Play for Ex-U.S. Exposure
Investors with just a casual familiarity with Colgate may be surprised to learn just how global this company is. Less than one-quarter of the company's sales come from within North America, which is considerably less than many well-known consumer names, like P&G, Coca-Cola (NYSE:KO), Newell Rubbermaid (NYSE:NWL) and Clorox (NYSE:CLX).

In fact, roughly 45% of the company's sales come from emerging markets. That's great for the company's growth prospects, but it also introduces a different set of risks. Not only does currency become a much bigger factor in results, but it leaves the company vulnerable to governments that don't always make fair or intelligent decisions. As a recent example, Venezuela has instituted price controls on various personal care items (like soap, etc.), on the basis of what its government deems a "fair" profit margin. This is not a Colgate-specific problem, but few others like Unilever or Johnson & Johnson (NYSE:JNJ) match Colgate's 5% exposure to this country.

The Bottom Line
I understand why Colgate-Palmolive is a popular company and stock. Management has stayed focused and has a good record of internal product development, to say nothing of consistent financial performance. It really is a top-notch blue chip dividend stock.

Still, there's a fair price for everything and Colgate stock seems beyond that. Not only are P&G and Unilever getting more aggressive, but global consumer spending growth is no certain thing in the coming year. I would be thrilled to buy Colgate stock in the mid-$70s, but today's price, even assuming relatively little deceleration in cash flow growth compared to the past decade, just seems a little too rich. (For related reading, see The Essentials Of Corporate Cash Flow.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Stephen Simpson did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Personal Finance

    A Day in the Life of an Equity Research Analyst

    What does an equity research analyst do on an everyday basis?
  2. Mutual Funds & ETFs

    ETF Analysis: PowerShares S&P 500 Downside Hedged

    Find out about the PowerShares S&P 500 Downside Hedged ETF, and learn detailed information about characteristics, suitability and recommendations of it.
  3. Mutual Funds & ETFs

    ETF Analysis: ProShares Large Cap Core Plus

    Learn information about the ProShares Large Cap Core Plus ETF, and explore detailed analysis of its characteristics, suitability and recommendations.
  4. Mutual Funds & ETFs

    ETF Analysis: iShares Core Growth Allocation

    Find out about the iShares Core Growth Allocation Fund, and learn detailed information about its characteristics, suitability and recommendations.
  5. Mutual Funds & ETFs

    ETF Analysis: iShares MSCI USA Minimum Volatility

    Learn about the iShares MSCI USA Minimum Volatility exchange-traded fund, which invests in low-volatility equities traded on the U.S. stock market.
  6. Stock Analysis

    Should You Follow Millionaires into This Sector?

    Millionaire investors—and those who follow them—should take another look at the current economic situation before making any more investment decisions.
  7. Professionals

    What to do During a Market Correction

    The market has corrected...now what? Here's what you should consider rather than panicking.
  8. Mutual Funds & ETFs

    ETF Analysis: Vanguard Mid-Cap Value

    Take an in-depth look at the Vanguard Mid-Cap Value ETF, one of the largest and most popular mid-cap funds in the U.S. equity space.
  9. Mutual Funds & ETFs

    ETF Analysis: Schwab US Broad Market

    Take an in-depth look at the Schwab U.S. Broad Market ETF, an incredibly low-cost fund based on a wide selection of the U.S. equity market.
  10. Professionals

    Tips for Helping Clients Though Market Corrections

    When the stock market sees a steep drop, clients are bound to get anxious. Here are some tips for talking them off the ledge.
RELATED TERMS
  1. Equity

    The value of an asset less the value of all liabilities on that ...
  2. Hard-To-Sell Asset

    An asset that is extremely difficult to dispose of either due ...
  3. Sucker Yield

    When an investor has essentially risked all of his capital for ...
  4. PT (Perseroan Terbatas)

    An acronym for Perseroan Terbatas, which is Limited Liability ...
  5. Ltd. (Limited)

    An abbreviation of "limited," Ltd. is a suffix that ...
  6. BHD (Berhad)

    The suffix Bhd. is an abbreviation of a Malay word "berhad," ...
RELATED FAQS
  1. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  2. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  3. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>
  6. What happens to the shares of stock purchased in a tender offer?

    The shares of stock purchased in a tender offer become the property of the purchaser. From that point forward, the purchaser, ... Read Full Answer >>

You May Also Like

COMPANIES IN THIS ARTICLE
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!